FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2098485474> ?p ?o ?g. }

• W2098485474 abstract "Permanent joint damage is a major consequence of rheumatoid arthritis (RA), the most common and destructive form of inflammatory arthritis. In aggressive disease, joint damage can occur within 6 months from symptom onset. Early, intensive treatment with conventional and biologic disease-modifying anti-rheumatic drugs (DMARDs) can delay the onset and progression of joint damage. The primary objective of the study is to investigate the value of magnetic resonance imaging (MRI) or radiography (X-ray) over standard of care as tools to guide DMARD treatment decision-making by rheumatologists for the care of RA. A double-blind, randomized controlled trial has been designed. Rheumatoid and undifferentiated inflammatory arthritis patients will undergo an MRI and X-ray assessment every 6 months. Baseline adaptive randomization will be used to allocate participants to MRI, X-ray, or sham-intervention groups on a background of standard of care. Prognostic markers, treating physician, and baseline DMARD therapy will be used as intervention allocation parameters. The outcome measures in rheumatology RA MRI score and the van der Heijde-modified Sharp score will be used to evaluate the MRI and X-ray images, respectively. Radiologists will score anonymized images for all patients regardless of intervention allocation. Disease progression will be determined based on the study-specific, inter-rater smallest detectable difference. Allocation-dependent, intervention-concealed reports of positive or negative disease progression will be reported to the treating rheumatologist. Negative reports will be delivered for the sham-intervention group. Study-based radiology clinical reports will be provided to the treating rheumatologists for extra-study X-ray requisitions to limit patient radiation exposure as part of diagnostic imaging standard of care. DMARD treatment dose escalation and therapy changes will be measured to evaluate the primary objective. A sample size of 186 (62 per group) patients will be required to determine a 36% difference in pharmacological treatment escalation between the three groups with intermediate dispersion of data with 90% power at a 5% level of significance. This study will determine if monitoring RA and undifferentiated inflammatory arthritis patients using MRI and X-ray every 6 months over 2 years provides incremental evidence over standard of care to influence pharmacotherapeutic decision-making and ultimately hinder disease progression. This trial has been registered at ClinicalTrials.gov: NCT00808496 (registered on 12 December 2008)." @default.
• W2098485474 created "2016-06-24" @default.
• W2098485474 creator A5007473204 @default.
• W2098485474 creator A5010566936 @default.
• W2098485474 creator A5023339952 @default.
• W2098485474 creator A5026563552 @default.
• W2098485474 creator A5032453977 @default.
• W2098485474 creator A5044493435 @default.
• W2098485474 creator A5049220408 @default.
• W2098485474 creator A5053098824 @default.
• W2098485474 creator A5053623177 @default.
• W2098485474 creator A5062747501 @default.
• W2098485474 creator A5072543250 @default.
• W2098485474 creator A5075047683 @default.
• W2098485474 creator A5075674236 @default.
• W2098485474 creator A5091486262 @default.
• W2098485474 date "2014-07-05" @default.
• W2098485474 modified "2023-10-16" @default.
• W2098485474 title "A double-blind, randomized controlled trial to compare the effect of biannual peripheral magnetic resonance imaging, radiography and standard of care disease progression monitoring on pharmacotherapeutic escalation in rheumatoid and undifferentiated inflammatory arthritis: study protocol for a randomized controlled trial" @default.
• W2098485474 cites W1596381381 @default.
• W2098485474 cites W1967095233 @default.
• W2098485474 cites W1974769907 @default.
• W2098485474 cites W1982176411 @default.
• W2098485474 cites W1983134858 @default.
• W2098485474 cites W2000366267 @default.
• W2098485474 cites W2004776451 @default.
• W2098485474 cites W2004901535 @default.
• W2098485474 cites W2006323210 @default.
• W2098485474 cites W2013005115 @default.
• W2098485474 cites W2015515502 @default.
• W2098485474 cites W2025317527 @default.
• W2098485474 cites W2026990996 @default.
• W2098485474 cites W2030682849 @default.
• W2098485474 cites W2042601236 @default.
• W2098485474 cites W2043343045 @default.
• W2098485474 cites W2045901968 @default.
• W2098485474 cites W2054076626 @default.
• W2098485474 cites W2054343352 @default.
• W2098485474 cites W2055122445 @default.
• W2098485474 cites W2058922006 @default.
• W2098485474 cites W2064353452 @default.
• W2098485474 cites W2065344034 @default.
• W2098485474 cites W2068080319 @default.
• W2098485474 cites W2075917870 @default.
• W2098485474 cites W2079732947 @default.
• W2098485474 cites W2083673654 @default.
• W2098485474 cites W2087228724 @default.
• W2098485474 cites W2089374347 @default.
• W2098485474 cites W2091222098 @default.
• W2098485474 cites W2096965824 @default.
• W2098485474 cites W2098497741 @default.
• W2098485474 cites W2105206310 @default.
• W2098485474 cites W2110177517 @default.
• W2098485474 cites W2117139373 @default.
• W2098485474 cites W2117810266 @default.
• W2098485474 cites W2118742196 @default.
• W2098485474 cites W2119359073 @default.
• W2098485474 cites W2122772946 @default.
• W2098485474 cites W2123037260 @default.
• W2098485474 cites W2124942406 @default.
• W2098485474 cites W2126074190 @default.
• W2098485474 cites W2140219205 @default.
• W2098485474 cites W2142399236 @default.
• W2098485474 cites W2143475422 @default.
• W2098485474 cites W2152348310 @default.
• W2098485474 cites W2152569901 @default.
• W2098485474 cites W2152897773 @default.
• W2098485474 cites W2156044760 @default.
• W2098485474 cites W2156652067 @default.
• W2098485474 cites W2157995380 @default.
• W2098485474 cites W2166732840 @default.
• W2098485474 cites W2168058439 @default.
• W2098485474 cites W2168711492 @default.
• W2098485474 cites W2169655406 @default.
• W2098485474 cites W2170225931 @default.
• W2098485474 cites W2170715239 @default.
• W2098485474 cites W2206746226 @default.
• W2098485474 cites W2467022164 @default.
• W2098485474 cites W2473786944 @default.
• W2098485474 cites W2763284518 @default.
• W2098485474 cites W4232603416 @default.
• W2098485474 cites W4235790631 @default.
• W2098485474 cites W4249398224 @default.
• W2098485474 cites W4318598792 @default.
• W2098485474 doi "https://doi.org/10.1186/1745-6215-15-268" @default.
• W2098485474 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4227117" @default.
• W2098485474 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24997587" @default.
• W2098485474 hasPublicationYear "2014" @default.
• W2098485474 type Work @default.
• W2098485474 sameAs 2098485474 @default.
• W2098485474 citedByCount "4" @default.
• W2098485474 countsByYear W20984854742015 @default.
• W2098485474 countsByYear W20984854742020 @default.
• W2098485474 crossrefType "journal-article" @default.
• W2098485474 hasAuthorship W2098485474A5007473204 @default.
• W2098485474 hasAuthorship W2098485474A5010566936 @default.
• W2098485474 hasAuthorship W2098485474A5023339952 @default.
• W2098485474 hasAuthorship W2098485474A5026563552 @default.
• W2098485474 hasAuthorship W2098485474A5032453977 @default.
• W2098485474 hasAuthorship W2098485474A5044493435 @default.

• next